Clinical Trials
15 trialsNCT05266157 2024-06-28
UroLymph
Universitaire Ziekenhuizen KU Leuven
Phase NA Unknown
NCT02266745 2024-04-05
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
Phase 2 Unknown
NCT05150236 2023-12-15
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
NCT05837598 2023-08-03
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
Phase NA Unknown
NCT04880681 2023-05-01
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Phase NA Unknown
NCT04784507 2022-04-12
En-Bloc Resection of Bladder Tumors
Medipol University
Phase 2 Unknown
NCT04831307 2021-12-03
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
British Columbia Cancer Agency
Phase NA Unknown
NCT05030077 2021-09-01
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT04922047 2021-06-11
TACBIN-01
RenJi Hospital
Phase 1/2 Unknown
NCT04644432 2020-11-25
INDIGO
Herlev and Gentofte Hospital
Phase 2 Unknown
NCT04556071 2020-11-10
AVANIRA3
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04566952 2020-10-30
ANLOLA
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04462926 2020-09-17
PSMA-PROSTAPET
Azienda Ospedaliero-Universitaria di Modena
Phase NA Unknown
NCT02836275 2020-04-14
IOTA-MRI
KU Leuven
Phase NA Unknown
NCT02049190 2015-06-24
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Arno Therapeutics
Phase 1/2 Unknown